• no-js

About RDM

The Radcliffe Department of Medicine (RDM), University of Oxford, is a large multi-disciplinary department with research interests that span the translational spectrum, from basic biological research through to clinical application.

The department has internationally renowned programmes in a broad range of sciences related to medicine, ranging from cardiovascular, diabetes, endocrinology, and stroke research, to molecular medicine, immunology, haematology and pathology, including programmes in stem cell & regenerative medicine.

The Radcliffe Department of Medicine, Oxford, is led by Prof Hugh Watkins. Read more

Athena SWAN

The Radcliffe Department of Medicine is fully committed to implementing the Athena SWAN initiative and supporting the careers of its students and staff. RDM currently holds a Silver award. Read more

Athena Swan

Latest News & Events

Mutations in genetically identical mice yield surprising results

Mutations in genetically identical mice yield surprising results

Posted 27/04/2017

Scientists have shown that inactivating the same gene in mouse embryos that are virtually genetically identical can result in a wide range of different physical features or abnormalities. The findings suggest that the relationship between gene mutation and consequence is more complex than ...

Star Wars in a petri dish

Star Wars in a petri dish

Posted 26/04/2017

A new method has been developed for observing the effects of drugs on heart cells under the microscope. Researchers from Oxford University created the technique to test the effects of new or commonly used drugs on heart function, as well as exploring new ways to treat diabetes. The new method ...

Research highlights need for responsible development of ketamine for severe depression

Research highlights need for responsible development of ketamine for severe depression

Posted 06/04/2017

A new paper, by Dr Rupert McShane from RDM, published in The Lancet Psychiatry, sets out principles for responsibly testing innovative treatments for severe depression, based on treating more than 100 patients with approximately 1,000 infusions of ketamine over six years in Oxford.

News Archive